Shire Plc (SHP)

Sector: Pharma and Biotech     Index: FTSE 100
-0.91%
-38.00p
4,125.00p
15:35 20/07/17
4,125.00p
15:35 20/07/17
DAILY VARIATION
-0.91%
-38.00p
VOLUME
1,132,377
REAL TIME BATS
4,098.50p
15:38 20/07/17
-1.32%
-55.00p
DATA
52 Week High
5,323.00p
52 Week Low
4,159.00p
Shares Issued
907.99m
Market Cap
£37,454.69m
RiskGrade
124
Beta
1.09
MENU

Shire Plc Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.6% 0.6%
Div Cover 2.6 13.9
Op Mrgn 8.4% 36.3%
ROCE 12.1%
Latest F'cast
P/E 69.6 10.9
PEG -1.1 0.0
Pr/Revenue 4.3 3.3
Pr/Book 1.7
Latest F'cast
Revenue 77.6% 14.4%
PBT -65.5% n/a
EPS -65.6% 10.3%
DPS 15.0% 11.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 4,527.40 1,008.80 145.10¢ 21.1 -2.8 -8% 17.33¢ 0.6%
2013-12-31 4,934.30 1,697.50 257.20¢ 18.4 0.2 77% 19.93¢ 0.4%
2014-12-31 6,022.10 3,338.90 559.60¢ 12.6 0.1 118% 22.92¢ 0.3%
2015-12-31 6,416.70 1,383.60 227.00¢ 30.5 -0.5 -59% 26.37¢ 0.4%
2016-12-31 11,396.60 477.40 78.00¢ 74.0 -1.1 -66% 30.33¢ 0.5%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 11,779.57 4,281.79 389.57p 10.9 0.0 544% 28.01p 0.7%
2018-12-31 12,562.67 4,863.02 442.01p 9.7 0.7 13% 31.92p 0.8%

Newspaper Links

No results found